Volume 30, Number 7—July 2024
Research
Prevalence of and Risk Factors for Post–COVID-19 Condition during Omicron BA.5–Dominant Wave, Japan
Table 1
Age group, y | Infected persons |
Noninfected persons |
Difference in response rates (95% CI) | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
HER-SYS† | No. participants | No. responses | Response rate, % | BRRS‡ | No. participants | No. responses | Response rate, % | ||||
Male patients | |||||||||||
20–29 | 3,404 | 2,979 | 611 | 20.5 | 3,404 | 2,979 | 574 | 19.3 | 1.2 (–3.3 to 5.7) | ||
30–39 | 3,806 | 3,328 | 1,120 | 33.7 | 3,806 | 3,328 | 896 | 26.9 | 6.8 (2.8–10.8) | ||
40–49 | 3,461 | 3,058 | 1,061 | 34.7 | 3,461 | 3,058 | 943 | 30.8 | 3.9 (–0.2 to 8.0) | ||
50–59 | 2,586 | 2,243 | 923 | 41.2 | 2,586 | 2,243 | 636 | 28.4 | 12.8 (8.1–17.5) | ||
60–69 | 1,152 | 1,024 | 413 | 40.3 | 1,152 | 1,024 | 326 | 31.8 | 8.5 (1.6–15.4) | ||
Subtotal |
14,409 |
12,632 |
4,129 |
32.7 |
14,409 |
12,632 |
3,375 |
26.7 |
6.0 (3.9–8.1) |
||
Female patients | |||||||||||
20–29 | 3,682 | 3,218 | 960 | 29.8 | 3,682 | 3,218 | 912 | 28.3 | 1.5 (–2.6 to 5.6) | ||
30–39 | 4,028 | 3,582 | 1,565 | 43.7 | 4,028 | 3,582 | 1,491 | 41.6 | 2.1 (–1.4 to 5.6) | ||
40–49 | 3,671 | 3,313 | 1,554 | 46.9 | 3,671 | 3,313 | 1,423 | 43.0 | 3.9 (3.2–7.5) | ||
50–59 | 2,386 | 2,166 | 971 | 44.8 | 2,386 | 2,166 | 884 | 40.8 | 4.0 (–0.5 to 8.5) | ||
60–69 | 1,100 | 1,000 | 402 | 40.2 | 1,100 | 1,000 | 333 | 33.3 | 6.9 (–0.1 to 13.9) | ||
Subtotal |
14,867 |
13,279 |
5,456 |
41.1 |
14,867 |
13,279 |
5,047 |
38.0 |
3.1 (1.2–5.0) |
||
Total | 29,276 | 25,911 | 9,668 | 37.3 | 29,276 | 25,911 | 8,515 | 32.9 | 4.4 (3.0–5.8) |
*BRRS, Basic Resident Registration system; HER-SYS, Health Center Real-Time Information-Sharing System. †Numbers of SARS-CoV-2–infected persons extracted from the HER-SYS database. ‡Numbers of age- and sex-adjusted noninfected persons extracted from the Basic Resident Registration system database.
Page created: June 05, 2024
Page updated: June 22, 2024
Page reviewed: June 22, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.